Blueprint Medicines (BPMC) Technical (Analysis) Reports Blueprint Medicines ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Blueprint Medicines (BPMC)
Technical Analysis Report for USA stock BPMC Blueprint Medicines. Dated: 03 Apr 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock BPMC Blueprint Medicines then click here. or read Experts views on Blueprint Medicines or Forecast & share price targets of Blueprint Medicines
Blueprint Medicines Opened at 86.36 and Closed at: 87.11, which is -3.33% of previous session's close. It moved within a range of 86.21 and 89.14
The session was a Bullish session with an average volume of 956000, which is -10.49% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Golden cross was found 6 days back on short term averages
Support for tomorrow is 86.66 and resistance for tomorrow is 89.59
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 85.83, 84.56 resistance for tomorrow's hourly charts is 88.76, 90.42
10 Day SMA for Blueprint Medicines (BPMC) is 89.28 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Blueprint Medicines (BPMC) is 89.2 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Blueprint Medicines (BPMC) is 97.48 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 96.1 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Blueprint Medicines is 96.69 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Blueprint Medicines is at 89.2 and 200 DMA is at 96.69, while 50 DMA and 100 DMA are at 97.48 and 96.1 respectively
Blueprint Medicines (BPMC) moving average of 20 SMA is at 89.2 and 20 EMA is at 90.13
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Thu Apr | 87.11 | 89.2 | 90.13 |
| 02 Wed Apr | 90.01 | 89.34 | 90.45 |
| 01 Tue Apr | 85.94 | 89.66 | 90.5 |
| 31 Mon Mar | 88.51 | 89.89 | 90.98 |
| 28 Fri Mar | 88.72 | 90.03 | 91.24 |
| 24 Mon Mar | 95.27 | 90.16 | 91.5 |
Blueprint Medicines (BPMC) moving average of 50 SMA is at 97.48 and 50 EMA is at 93.36
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Thu Apr | 87.11 | 97.48 | 93.36 |
| 02 Wed Apr | 90.01 | 97.94 | 93.62 |
| 01 Tue Apr | 85.94 | 98.34 | 93.77 |
| 31 Mon Mar | 88.51 | 98.7 | 94.09 |
| 28 Fri Mar | 88.72 | 99.03 | 94.32 |
| 24 Mon Mar | 95.27 | 99.31 | 94.55 |
Blueprint Medicines (BPMC) moving average of 100 SMA is at 96.1 and 100 EMA is at 94.75
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Thu Apr | 87.11 | 96.1 | 94.75 |
| 02 Wed Apr | 90.01 | 96.12 | 94.9 |
| 01 Tue Apr | 85.94 | 96.05 | 95 |
| 31 Mon Mar | 88.51 | 96.02 | 95.18 |
| 28 Fri Mar | 88.72 | 95.96 | 95.31 |
| 24 Mon Mar | 95.27 | 95.91 | 95.44 |
Blueprint Medicines (BPMC) moving average of 200 SMA is at 96.69 and 200 EMA is at 93.27
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Thu Apr | 87.11 | 96.69 | 93.27 |
| 02 Wed Apr | 90.01 | 96.79 | 93.33 |
| 01 Tue Apr | 85.94 | 96.87 | 93.36 |
| 31 Mon Mar | 88.51 | 96.96 | 93.43 |
| 28 Fri Mar | 88.72 | 97.04 | 93.48 |
| 24 Mon Mar | 95.27 | 97.11 | 93.53 |
Blueprint Medicines has performed better than Enzo Biochem in short term. Holding Blueprint Medicines could be a better choice for now!
Blueprint Medicines has performed better than Boston Scientific in short term. Holding Blueprint Medicines could be a better choice for now!
Blueprint Medicines has performed better than Viking Therapeutics in short term. Holding Blueprint Medicines could be a better choice for now!
Supernus Pharmaceuticals has performed better than Blueprint Medicines in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 5.19% more returns!
Blueprint Medicines has performed better than Radnet Inc in short term. Holding Blueprint Medicines could be a better choice for now!
Pro Dex has performed better than Blueprint Medicines in short term. You could have earned much better returns by investing in Pro Dex, about 50.12% more returns!
Blueprint Medicines has performed better than Medpace Holdings in short term. Holding Blueprint Medicines could be a better choice for now!
Blueprint Medicines has performed better than Livanova Plc in short term. Holding Blueprint Medicines could be a better choice for now!
Blueprint Medicines has performed better than Iterum Therapeutics in short term. Holding Blueprint Medicines could be a better choice for now!
Blueprint Medicines has performed better than Intuitive Surgical in short term. Holding Blueprint Medicines could be a better choice for now!
Blueprint Medicines has performed better than Inovio Pharmaceuticals in short term. Holding Blueprint Medicines could be a better choice for now!
Blueprint Medicines has performed better than Incyte Corporation in short term. Holding Blueprint Medicines could be a better choice for now!
Hologic Inc has performed better than Blueprint Medicines in short term. You could have earned much better returns by investing in Hologic Inc, about 1.56% more returns!
Fortress Biotech has performed better than Blueprint Medicines in short term. You could have earned much better returns by investing in Fortress Biotech, about 1.89% more returns!
Blueprint Medicines has performed better than Establishment Labs in short term. Holding Blueprint Medicines could be a better choice for now!
Corcept Therapeutics has performed better than Blueprint Medicines in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 44.3% more returns!
Cara Therapeutics has performed better than Blueprint Medicines in short term. You could have earned much better returns by investing in Cara Therapeutics, about 14.28% more returns!
Blueprint Medicines Technical analysis of indicators
Price action analysis of Blueprint Medicines (BPMC) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 89.42 and Blueprint Medicines BPMC stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines BPMC stock. Volume based technical analysis of Blueprint Medicines BPMC stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock BPMC Blueprint Medicines These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BPMC Experts View which covers a lot of information including buying and selling signals
BPMC future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Blueprint Medicines or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Blueprint Medicines (BPMC) Technical (Analysis) Reports Blueprint Medicines ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance